La bourse est fermée
  • CAC 40

    5 559,57
    -31,22 (-0,56 %)
     
  • Euro Stoxx 50

    3 602,41
    -15,94 (-0,44 %)
     
  • Dow Jones

    30 996,98
    -179,03 (-0,57 %)
     
  • EUR/USD

    1,2174
    +0,0001 (+0,01 %)
     
  • Gold future

    1 855,50
    -10,40 (-0,56 %)
     
  • BTC-EUR

    26 142,13
    -688,87 (-2,57 %)
     
  • CMC Crypto 200

    651,44
    +41,45 (+6,79 %)
     
  • Pétrole WTI

    51,98
    -1,15 (-2,16 %)
     
  • DAX

    13 873,97
    -32,70 (-0,24 %)
     
  • FTSE 100

    6 695,07
    -20,35 (-0,30 %)
     
  • Nasdaq

    13 543,06
    +12,15 (+0,09 %)
     
  • S&P 500

    3 841,47
    -11,60 (-0,30 %)
     
  • Nikkei 225

    28 631,45
    -125,41 (-0,44 %)
     
  • HANG SENG

    29 447,85
    -479,91 (-1,60 %)
     
  • GBP/USD

    1,3684
    -0,0046 (-0,34 %)
     

Global Pharmacovigilance and Drug Safety Software Industry

ReportLinker
·12 min de lecture

Global Pharmacovigilance and Drug Safety Software Market to Reach $201. 8 Million by 2027. Amid the COVID-19 crisis, the global market for Pharmacovigilance and Drug Safety Software estimated at US$143 Million in the year 2020, is projected to reach a revised size of US$201.

New York, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pharmacovigilance and Drug Safety Software Industry" - https://www.reportlinker.com/p05957678/?utm_source=GNW
8 Million by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. ADR Reporting, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$92 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Safety Audits segment is readjusted to a revised 4.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $42.1 Million, While China is Forecast to Grow at 4.8% CAGR

The Pharmacovigilance and Drug Safety Software market in the U.S. is estimated at US$42.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$35.7 Million by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Issue Tracking Segment to Record 5.4% CAGR

In the global Issue Tracking segment, USA, Canada, Japan, China and Europe will drive the 5.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$19.8 Million in the year 2020 will reach a projected size of US$28.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$23.3 Million by the year 2027.We bring years of research experience to this 6th edition of our report. The 181-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • AB Cube

  • ArisGlobal LLC

  • Ennov USA

  • Extedo GmbH

  • Online Business Applications, Inc.

  • Oracle Corporation

  • Sarjen Systems Pvt. Ltd.

  • Sparta Systems, Inc.

  • United Biosource Corporation




Read the full report: https://www.reportlinker.com/p05957678/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Pharmacovigilance and Drug Safety Software Competitor Market
Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Pharmacovigilance and Drug Safety Software Global
Market Estimates and Forecasts in US$ by Region/Country:
2020-2027

Table 2: Pharmacovigilance and Drug Safety Software Market
Share Shift across Key Geographies Worldwide: 2020 VS 2027

Table 3: ADR Reporting (Functionality) World Market by
Region/Country in US$: 2020 to 2027

Table 4: ADR Reporting (Functionality) Market Share Breakdown
of Worldwide Sales by Region/Country: 2020 VS 2027

Table 5: Drug Safety Audits (Functionality) Potential Growth
Markets Worldwide in US$: 2020 to 2027

Table 6: Drug Safety Audits (Functionality) Market Sales
Breakdown by Region/Country in Percentage: 2020 VS 2027

Table 7: Issue Tracking (Functionality) Geographic Market
Spread Worldwide in US$: 2020 to 2027

Table 8: Issue Tracking (Functionality) Market Share
Distribution in Percentage by Region/Country: 2020 VS 2027

Table 9: Fully Integrated Software (Functionality) World Market
Estimates and Forecasts by Region/Country in US$: 2020 to 2027

Table 10: Fully Integrated Software (Functionality) Market
Share Breakdown by Region/Country: 2020 VS 2027

Table 11: Pharma & Biotech Companies (End-Use) Worldwide Latent
Demand Forecasts in US$ by Region/Country: 2020-2027

Table 12: Pharma & Biotech Companies (End-Use) Distribution of
Global Sales by Region/Country: 2020 VS 2027

Table 13: CROs (End-Use) Sales Estimates and Forecasts in US$
by Region/Country for the Years 2020 through 2027

Table 14: CROs (End-Use) Global Market Share Distribution by
Region/Country for 2020 and 2027

Table 15: BPOs (End-Use) Global Opportunity Assessment in US$
by Region/Country: 2020-2027

Table 16: BPOs (End-Use) Percentage Share Breakdown of Global
Sales by Region/Country: 2020 VS 2027

Table 17: Other End-Uses (End-Use) Worldwide Sales in US$ by
Region/Country: 2020-2027

Table 18: Other End-Uses (End-Use) Market Share Shift across
Key Geographies: 2020 VS 2027

Table 19: On-premise (Deployment Model) Potential Growth
Markets Worldwide in US$: 2020 to 2027

Table 20: On-premise (Deployment Model) Market Sales Breakdown
by Region/Country in Percentage: 2020 VS 2027

Table 21: On-demand (Deployment Model) Geographic Market Spread
Worldwide in US$: 2020 to 2027

Table 22: On-demand (Deployment Model) Market Share
Distribution in Percentage by Region/Country: 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Pharmacovigilance and Drug Safety Software Market Share
(in %) by Company: 2019 & 2025
Market Analytics
Table 23: United States Pharmacovigilance and Drug Safety
Software Market Estimates and Projections in US$ by
Functionality: 2020 to 2027

Table 24: United States Pharmacovigilance and Drug Safety
Software Market Share Breakdown by Functionality: 2020 VS 2027

Table 25: United States Pharmacovigilance and Drug Safety
Software Latent Demand Forecasts in US$ by End-Use: 2020 to
2027

Table 26: Pharmacovigilance and Drug Safety Software Market
Share Breakdown in the United States by End-Use: 2020 VS 2027

Table 27: United States Pharmacovigilance and Drug Safety
Software Market Estimates and Projections in US$ by Deployment
Model: 2020 to 2027

Table 28: United States Pharmacovigilance and Drug Safety
Software Market Share Breakdown by Deployment Model: 2020 VS
2027

CANADA
Table 29: Canadian Pharmacovigilance and Drug Safety Software
Market Estimates and Forecasts in US$ by Functionality: 2020 to
2027

Table 30: Pharmacovigilance and Drug Safety Software Market in
Canada: Percentage Share Breakdown of Sales by Functionality
for 2020 and 2027

Table 31: Canadian Pharmacovigilance and Drug Safety Software
Market Quantitative Demand Analysis in US$ by End-Use: 2020 to
2027

Table 32: Canadian Pharmacovigilance and Drug Safety Software
Market Share Analysis by End-Use: 2020 VS 2027

Table 33: Canadian Pharmacovigilance and Drug Safety Software
Market Estimates and Forecasts in US$ by Deployment Model: 2020
to 2027

Table 34: Pharmacovigilance and Drug Safety Software Market in
Canada: Percentage Share Breakdown of Sales by Deployment Model
for 2020 and 2027

JAPAN
Table 35: Japanese Market for Pharmacovigilance and Drug Safety
Software: Annual Sales Estimates and Projections in US$ by
Functionality for the Period 2020-2027

Table 36: Japanese Pharmacovigilance and Drug Safety Software
Market Share Analysis by Functionality: 2020 VS 2027

Table 37: Japanese Demand Estimates and Forecasts for
Pharmacovigilance and Drug Safety Software in US$ by End-Use:
2020 to 2027

Table 38: Pharmacovigilance and Drug Safety Software Market
Share Shift in Japan by End-Use: 2020 VS 2027

Table 39: Japanese Market for Pharmacovigilance and Drug Safety
Software: Annual Sales Estimates and Projections in US$ by
Deployment Model for the Period 2020-2027

Table 40: Japanese Pharmacovigilance and Drug Safety Software
Market Share Analysis by Deployment Model: 2020 VS 2027

CHINA
Table 41: Chinese Pharmacovigilance and Drug Safety Software
Market Growth Prospects in US$ by Functionality for the Period
2020-2027

Table 42: Chinese Pharmacovigilance and Drug Safety Software
Market by Functionality: Percentage Breakdown of Sales for 2020
and 2027

Table 43: Chinese Demand for Pharmacovigilance and Drug Safety
Software in US$ by End-Use: 2020 to 2027

Table 44: Chinese Pharmacovigilance and Drug Safety Software
Market Share Breakdown by End-Use: 2020 VS 2027

Table 45: Chinese Pharmacovigilance and Drug Safety Software
Market Growth Prospects in US$ by Deployment Model for the
Period 2020-2027

Table 46: Chinese Pharmacovigilance and Drug Safety Software
Market by Deployment Model: Percentage Breakdown of Sales for
2020 and 2027

EUROPE
Market Facts & Figures
European Pharmacovigilance and Drug Safety Software Market:
Competitor Market Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 47: European Pharmacovigilance and Drug Safety Software
Market Demand Scenario in US$ by Region/Country: 2018-2025

Table 48: European Pharmacovigilance and Drug Safety Software
Market Share Shift by Region/Country: 2020 VS 2027

Table 49: European Pharmacovigilance and Drug Safety Software
Market Estimates and Forecasts in US$ by Functionality:
2020-2027

Table 50: European Pharmacovigilance and Drug Safety Software
Market Share Breakdown by Functionality: 2020 VS 2027

Table 51: European Pharmacovigilance and Drug Safety Software
Addressable Market Opportunity in US$ by End-Use: 2020-2027

Table 52: European Pharmacovigilance and Drug Safety Software
Market Share Analysis by End-Use: 2020 VS 2027

Table 53: European Pharmacovigilance and Drug Safety Software
Market Estimates and Forecasts in US$ by Deployment Model:
2020-2027

Table 54: European Pharmacovigilance and Drug Safety Software
Market Share Breakdown by Deployment Model: 2020 VS 2027

FRANCE
Table 55: Pharmacovigilance and Drug Safety Software Market in
France by Functionality: Estimates and Projections in US$ for
the Period 2020-2027

Table 56: French Pharmacovigilance and Drug Safety Software
Market Share Analysis by Functionality: 2020 VS 2027

Table 57: Pharmacovigilance and Drug Safety Software
Quantitative Demand Analysis in France in US$ by End-Use:
2020-2027

Table 58: French Pharmacovigilance and Drug Safety Software
Market Share Analysis: A 7-Year Perspective by End-Use for 2020
and 2027

Table 59: Pharmacovigilance and Drug Safety Software Market in
France by Deployment Model: Estimates and Projections in US$
for the Period 2020-2027

Table 60: French Pharmacovigilance and Drug Safety Software
Market Share Analysis by Deployment Model: 2020 VS 2027

GERMANY
Table 61: Pharmacovigilance and Drug Safety Software Market in
Germany: Recent Past, Current and Future Analysis in US$ by
Functionality for the Period 2020-2027

Table 62: German Pharmacovigilance and Drug Safety Software
Market Share Breakdown by Functionality: 2020 VS 2027

Table 63: Pharmacovigilance and Drug Safety Software Market in
Germany: Annual Sales Estimates and Forecasts in US$ by End-Use
for the Period 2020-2027

Table 64: Pharmacovigilance and Drug Safety Software Market
Share Distribution in Germany by End-Use: 2020 VS 2027

Table 65: Pharmacovigilance and Drug Safety Software Market in
Germany: Recent Past, Current and Future Analysis in US$ by
Deployment Model for the Period 2020-2027

Table 66: German Pharmacovigilance and Drug Safety Software
Market Share Breakdown by Deployment Model: 2020 VS 2027

ITALY
Table 67: Italian Pharmacovigilance and Drug Safety Software
Market Growth Prospects in US$ by Functionality for the Period
2020-2027

Table 68: Italian Pharmacovigilance and Drug Safety Software
Market by Functionality: Percentage Breakdown of Sales for 2020
and 2027

Table 69: Italian Demand for Pharmacovigilance and Drug Safety
Software in US$ by End-Use: 2020 to 2027

Table 70: Italian Pharmacovigilance and Drug Safety Software
Market Share Breakdown by End-Use: 2020 VS 2027

Table 71: Italian Pharmacovigilance and Drug Safety Software
Market Growth Prospects in US$ by Deployment Model for the
Period 2020-2027

Table 72: Italian Pharmacovigilance and Drug Safety Software
Market by Deployment Model: Percentage Breakdown of Sales for
2020 and 2027

UNITED KINGDOM
Table 73: United Kingdom Market for Pharmacovigilance and Drug
Safety Software: Annual Sales Estimates and Projections in US$
by Functionality for the Period 2020-2027

Table 74: United Kingdom Pharmacovigilance and Drug Safety
Software Market Share Analysis by Functionality: 2020 VS 2027

Table 75: United Kingdom Demand Estimates and Forecasts for
Pharmacovigilance and Drug Safety Software in US$ by End-Use:
2020 to 2027

Table 76: Pharmacovigilance and Drug Safety Software Market
Share Shift in the United Kingdom by End-Use: 2020 VS 2027

Table 77: United Kingdom Market for Pharmacovigilance and Drug
Safety Software: Annual Sales Estimates and Projections in US$
by Deployment Model for the Period 2020-2027

Table 78: United Kingdom Pharmacovigilance and Drug Safety
Software Market Share Analysis by Deployment Model: 2020 VS
2027

REST OF EUROPE
Table 79: Rest of Europe Pharmacovigilance and Drug Safety
Software Market Estimates and Forecasts in US$ by
Functionality: 2020-2027

Table 80: Rest of Europe Pharmacovigilance and Drug Safety
Software Market Share Breakdown by Functionality: 2020 VS 2027

Table 81: Rest of Europe Pharmacovigilance and Drug Safety
Software Addressable Market Opportunity in US$ by End-Use:
2020-2027

Table 82: Rest of Europe Pharmacovigilance and Drug Safety
Software Market Share Analysis by End-Use: 2020 VS 2027

Table 83: Rest of Europe Pharmacovigilance and Drug Safety
Software Market Estimates and Forecasts in US$ by Deployment
Model: 2020-2027

Table 84: Rest of Europe Pharmacovigilance and Drug Safety
Software Market Share Breakdown by Deployment Model: 2020 VS
2027

ASIA-PACIFIC
Table 85: Pharmacovigilance and Drug Safety Software Market in
Asia-Pacific by Functionality: Estimates and Projections in US$
for the Period 2020-2027

Table 86: Asia-Pacific Pharmacovigilance and Drug Safety
Software Market Share Analysis by Functionality: 2020 VS 2027

Table 87: Pharmacovigilance and Drug Safety Software
Quantitative Demand Analysis in Asia-Pacific in US$ by End-Use:
2020-2027

Table 88: Asia-Pacific Pharmacovigilance and Drug Safety
Software Market Share Analysis: A 7-Year Perspective by End-Use
for 2020 and 2027

Table 89: Pharmacovigilance and Drug Safety Software Market in
Asia-Pacific by Deployment Model: Estimates and Projections in
US$ for the Period 2020-2027

Table 90: Asia-Pacific Pharmacovigilance and Drug Safety
Software Market Share Analysis by Deployment Model: 2020 VS
2027

REST OF WORLD
Table 91: Rest of World Pharmacovigilance and Drug Safety
Software Market Estimates and Forecasts in US$ by
Functionality: 2020 to 2027

Table 92: Pharmacovigilance and Drug Safety Software Market in
Rest of World: Percentage Share Breakdown of Sales by
Functionality for 2020 and 2027

Table 93: Rest of World Pharmacovigilance and Drug Safety
Software Market Quantitative Demand Analysis in US$ by End-Use:
2020 to 2027

Table 94: Rest of World Pharmacovigilance and Drug Safety
Software Market Share Analysis by End-Use: 2020 VS 2027

Table 95: Rest of World Pharmacovigilance and Drug Safety
Software Market Estimates and Forecasts in US$ by Deployment
Model: 2020 to 2027

Table 96: Pharmacovigilance and Drug Safety Software Market in
Rest of World: Percentage Share Breakdown of Sales by
Deployment Model for 2020 and 2027

IV. COMPETITION
Total Companies Profiled: 47
Read the full report: https://www.reportlinker.com/p05957678/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001